Substances of abuse dysregulate key brain systems involved in motivation, reward, decision-making and memory. As drug use evolves into a compulsive addiction, there are adaptations in these systems, mediated by a number of different neurotransmitters. The mesolimbic dopaminergic pathway plays a central role in the reinforcing effects of drugs and the development of addiction. As addiction develops, there is a shift away from positive reinforcement to compulsive, habitual drug-seeking behaviours driven, for example, by craving or aversive withdrawal symptoms. Although the potential for addiction is common to many drugs, the underlying mechanisms, neurotransmission systems and adaptations vary between drugs. This review focuses on the neurobiology of addiction and tolerance for substances including alcohol, benzodiazepines, opioids and stimulants.
Delirium is a common neuropsychiatric syndrome. However, it is often misdiagnosed and management can be inconsistent and distressing for patients and their families. It has a diverse multifactorial aetiology and results in cerebral dysfunction. The criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, and the International Classification of Diseases, 11th revision, are increasingly unified in describing the core symptoms and profile. The new profiles are characterized by an acute disturbance of attention with a fluctuating pattern and impaired cognition. These profiles then incorporate non-cognitive symptoms, including disordered thinking and hallucinations. Non-pharmacological interventions prioritize staff training, early intervention including physiotherapy, a review of medications and environmental adaptations. Potential pharmacological approaches include the careful use of sedation and low-dose antipsychotics.